2.825USD+0.89%Mkt Cap: 12.52M USDP/E: —Last update: 2026-06-01
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a poten…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.52M USD
Enterprise Value-1.62M USD
Revenue (TTM)—
Gross Profit-3.71M USD
Net Income (TTM)-10.84M USD
Revenue/Share—
Last Price2.825 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.20
PEG—
EV/EBITDA0.16
EV/Revenue—
P/S—
P/B0.77
EPS (TTM)-2.70
EPS (Forward)-2.23
52W Range
1.76544% of range4.180
52W High4.180 USD
52W Low1.765 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.19%
ROA-44.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.96M USD
CapEx (TTM)110.79K USD
FCF Margin—
FCF Yield-76.51%
Net Debt-13.50M USD
Net Debt/EBITDA1.37
Balance Sheet
Debt/Equity0.02
Current Ratio6.68
Quick Ratio6.19
Book Value/Sh3.489 USD
Cash/Share3.130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 30, 2019
Splits
Last Split1:9
Split DateJun 11, 2024
Analyst Consensus
Rating—
Target (Mean)12.00 USD
Target Range12.00 USD – 12.00 USD
# Analysts1
Ownership
Shares Out.4.43M
Float4.30M
Insiders3.05%
Institutions28.80%
Short Interest
Short Ratio0.3d
Short % Float0.51%
Short % Out.0.50%
Shares Short22.00K
Short (prev mo.)28.66K
Technical
SMA 502.371 (+19.1%)
SMA 2002.334 (+21.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)54.17K
Avg Vol (10d)55.43K
Technical Indicators
RSI (14)64.6
MACD0.1005
MACD Signal0.0806
MACD Hist.+0.0199
BB Upper2.820 USD
BB Middle2.572 USD
BB Lower2.324 USD
BB Width19.29%
ATR (14)0.1432 USD
Vol Ratio (20d)0.48x